Merck Disputes Patent Board Findings In Federal Circuit Appeal
WASHINGTON, D.C. — In an Oct. 24 appellant brief, Merck, Sharp & Dohme Corp. maintains that the Patent Trial and Appeal Board erred in confirming as patentable various claims of three...To view the full article, register now.
Already a subscriber? Click here to view full article